Position in VTRS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,880,332
+$290,732 QoQ
Shares Held
213,200
+2.5% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GABELLI FUNDS LLC holds $36,352,371 across 10 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
332,900 | $10,026,948 | |
| 2 | PRGO |
PERRIGO Co plc
|
893,359 | $9,594,675 | |
| 3 | ZTS |
Zoetis Inc.
|
60,450 | $7,145,794 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
134,250 | $3,212,602 | |
| 5 | VTRS |
Viatris Inc
This page
|
213,200 | $2,880,332 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
24,000 | $1,820,400 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
23,000 | $1,188,870 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
56,000 | $302,400 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,880,332 | 213,200 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,589,600 | 208,000 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,059,200 | 208,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,888,695 | 211,500 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,846,520 | 212,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,654,340 | 213,200 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,577,420 | 222,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,466,160 | 232,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,973,060 | 249,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,783,310 | 257,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,839,680 | 288,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,218,550 | 322,500 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,210,194 | 333,700 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,784,200 | 340,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,160,920 | 371,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,161,825 | 397,500 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,428,160 | 407,000 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $4,830,210 | 357,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,918,145 | 289,162 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,035,610 | 352,387 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,306,546 | 451,435 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,586,101 | 404,808 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||